{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:12:36Z","timestamp":1761822756109},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.clineuro.2005.01.002","type":"journal-article","created":{"date-parts":[[2005,2,21]],"date-time":"2005-02-21T12:19:03Z","timestamp":1108988343000},"page":"32-35","source":"Crossref","is-referenced-by-count":20,"title":["Olanzapine versus propranolol in essential tremor"],"prefix":"10.1016","volume":"108","author":[{"given":"Ye\u015fim","family":"Yetimalar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcl\u00fcmser","family":"Irtman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00fclay","family":"Kurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Ba\u015fo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2005.01.002_bib1","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1212\/WNL.37.7.1194","article-title":"Essential tremor: a review","volume":"37","author":"Findley","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2005.01.002_bib2","series-title":"Parkinson's disease and movement disorders","first-page":"293","article-title":"Tremors: differential diagnosis and pharmacology","author":"Findley","year":"1993"},{"key":"10.1016\/j.clineuro.2005.01.002_bib3","unstructured":"Findley LJ, Koller WC, Le Witt P. Classification and definition of tremor. In: Lord Walton of Detchan, ed. Indications for and clinical implications of botulinum toxin therapy. Royal Society of Medicine, London; 1993. p. 22\u20133."},{"key":"10.1016\/j.clineuro.2005.01.002_bib4","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1227\/00006123-199510000-00011","article-title":"Outcome after stereotaxic thalamotomy for parkinsonism, essential, and other types tremor","volume":"37","author":"Jankovic","year":"1995","journal-title":"Neurosurgery"},{"key":"10.1016\/j.clineuro.2005.01.002_bib5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.410420304","article-title":"High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor","volume":"42","author":"Koller","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clineuro.2005.01.002_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000100201","article-title":"Long-term results of stereotaxy in the treatment of essential tremor","volume":"45","author":"Mohadjer","year":"1990","journal-title":"Stereotact Funct Neurosurg"},{"key":"10.1016\/j.clineuro.2005.01.002_bib7","first-page":"2","article-title":"Essential tremor","volume":"54","author":"Koller","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2005.01.002_bib8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/1531-8257(199905)14:3<468::AID-MDS1013>3.0.CO;2-M","article-title":"Acute and chronic effects of clozapine in essential tremor","volume":"14","author":"Ceravolo","year":"1999","journal-title":"Mov Disord"},{"key":"10.1016\/j.clineuro.2005.01.002_bib9","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1212\/WNL.48.4.1077","article-title":"Benztropine versus clozapine for the treatment of tremor in Parkinson's disease","volume":"48","author":"Friedman","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2005.01.002_bib10","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1212\/WNL.49.6.1587","article-title":"Clozapine in Parkinson's disease tremor: effects of acute and chronic administration","volume":"49","author":"Bonuccelli","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2005.01.002_bib11","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/mds.870130517","article-title":"A case of tardive tremor successfully treated with clozapine","volume":"13","author":"Delecluse","year":"1998","journal-title":"Mov Disord"},{"key":"10.1016\/j.clineuro.2005.01.002_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1600-0404.1986.tb03279.x","article-title":"Clozapine in the treatment of tremor","volume":"73","author":"Pakkenberg","year":"1986","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.clineuro.2005.01.002_bib13","first-page":"47","article-title":"An overview of the mechanism of action of clozapine","volume":"55","author":"Meltzer","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clineuro.2005.01.002_bib14","first-page":"112","article-title":"Olanzapine, a novel antipsychotic","author":"Taran","year":"2000","journal-title":"Williams & Wilkins healthcare"},{"key":"10.1016\/j.clineuro.2005.01.002_bib15","series-title":"Movement disorders. Neurologic principles and practice","author":"Watts","year":"1997"},{"key":"10.1016\/j.clineuro.2005.01.002_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1212\/WNL.54.9.30A","article-title":"Pharmacologic treatment of essential tremor","volume":"54","author":"Koller","year":"2000","journal-title":"Neurol"},{"issue":"12","key":"10.1016\/j.clineuro.2005.01.002_bib17","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.4088\/JCP.v63n1208","article-title":"The risk of diabetes during olanzapine use compared with risperidone use: a retrospective database analysis","volume":"63","author":"Caro","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clineuro.2005.01.002_bib18","doi-asserted-by":"crossref","unstructured":"Bobes J, Rejas J, Garcia-Garcia M, Rico-Villademoros F, Garca-Portilla MP, Fernandez I, et al. Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study. Schizophrenia Research, Elsevier Sci 62;2003:77\u201388.","DOI":"10.1016\/S0920-9964(02)00431-0"},{"issue":"3","key":"10.1016\/j.clineuro.2005.01.002_bib19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1345\/aph.1A207","article-title":"New-onset seizure associated with quetiapine and olanzapine","volume":"36","author":"Hedges","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clineuro.2005.01.002_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1468-1331.2003.00534.x","article-title":"Olanzapine efficacy in the treatment of essential tremor","volume":"10","author":"Yetimalar","year":"2003","journal-title":"Eur J Neurol"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846705000090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846705000090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T17:09:36Z","timestamp":1548695376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846705000090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0303846705000090"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2005.01.002","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}